Skip to main content
← All exclusions

Anavex Life Sciences Corp.

AVXL

Health Care

1

exclusion reason

1 theme

Animal Welfare (1)
AVXL Health Care Current as of April 2026

This page is part of our public exclusion list — a transparency tool that shows which companies we screen out and why. It is not investment advice, and it is not an accusation. But it is subject to change as our understanding of the facts evolves.

Animal Testing & Research
Since Jul 28, 2021

Anavex Life Sciences Corp. is a clinical-stage biopharmaceutical company whose drug development pipeline necessitates animal testing for regulatory compliance. The company’s lead drug candidate, ANAVEX®2-73 (blarcamesine), has progressed through Phase 2a and Phase 2b/3 clinical trials for Alzheimer’s disease. As disclosed in its 2025 Form 10-K, the company’s non-clinical testing includes laboratory evaluation of potential drug compounds and animal studies to assess chemistry, formulation, and toxicity. This reliance on animal data is a standard, required step for advancing therapeutic candidates through the regulatory approval process. The company’s Supplier Code of Conduct references corporate integrity but does not articulate a policy against animal testing.

Research Sources 1 organization
Cruelty Free Investors
External

Wondering what we do invest in?

The Naughty List

A digest of changes to our exclusion list — new additions, removals, and the evidence behind them. We review the list continuously as new evidence surfaces.

RSS feed No spam · Unsubscribe anytime

Companies appear on our exclusion list based on our investment judgment — not because they've done anything illegal. This is a difference of values and opinion, not an accusation of wrongdoing. Exclusion does not constitute a recommendation against investing in any company, and absence from the list does not constitute a recommendation to invest.

This information is provided for educational and transparency purposes only and should not be relied upon as investment advice. Data is drawn from independent watchdogs, NGOs, government registries, and Ethical Capital's ongoing research — see Research Sources for the full list.

Ethical Capital LLC is a state-registered investment adviser in Utah (CRD #316032). Registration does not imply a certain level of skill or training.